Endothelial exocytosis and the vascular dysfunction of aging
Endothelial exocytosis and the vascular dysfunction of aging
批准号:
7878227
负责人:
NICHOLAS A FLAVAHAN
金额:
$20.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-12 至 2012-03-31
关键词:
AffectAgeAgingAnimalsArteriesBlood VesselsCardiovascular systemCellsCytoplasmic GranulesDilatorDiseaseElderlyEndothelial CellsEndothelinEndothelin-1EndotheliumExocytosisFunctional disorderGenerationsInbred F344 RatsInflammatoryIschemiaLaser Scanning Confocal MicroscopyMediatingMediator of activation proteinMicrocirculationModern MedicineNitric OxideOrganPathologyPeptidesPhysiciansPlayPre-Clinical ModelProcessProductionPublished CommentRattusRegulation of ExocytosisReperfusion TherapyReportingResearchRoleSignal TransductionSplanchnic CirculationStaining methodStainsStressTestingThrombinVasomotorWeibel-Palade Bodiesage effectageddesigninhibitor/antagonistnovelnovel strategiesoxidant stresspublic health relevancereceptorresearch studyresponsevon Willebrand Factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The aging endothelium is characterized by reduced activity of the endothelial dilator NO, increased production of ROS and oxidant stress, and increased inflammatory and thrombotic activity. Endothelial storage granules, including Weibel-Palade Bodies (WPBs) contain numerous mediators that play important roles in regulating vasomotor, thrombotic and inflammatory processes, and can be rapidly released by stimulated exocytosis. It is likely that exocytosis and release of these endothelial granules play an important role in the vascular pathology associated with aging. However, no previous studies have directly assessed the effects of aging on this fundamental mechanism. In novel preliminary results, we demonstrate that native endothelium of aging blood vessels have increased ability to generate and release pathophysiological mediators (including endothelin-1) during stimulated exocytosis. Our overall hypothesis is that increased release and generation of endothelial mediators by stimulated exocytosis contributes to vascular dysfunction in aging. We hope that by increasing our understanding of how aging affects this fundamental mechanism, it may provide novel approaches to treat diseases associated with aging. We will test our hypotheses on native endothelium of young and aging blood vessels, using the Fischer rat preclinical model of aging. Three specific aims are proposed to: AIM 1: DETERMINE THE INFLUENCE OF AGING ON THE GENERATION AND EXOCYTOSIS OF ENDOTHELIN-1 FROM ENDOTHELIUM. These experiments will focus on evaluating the increased ability of aging endothelium to generate endothelin-1 (ET-1) during exocytosis. Experiments will investigate the expression, processing and exocytotic release of ET-1 from the endothelium of young and aging blood vessels. AIM 2: DETERMINE THE ROLE OF NITRIC OXIDE IN REGULATING ENDOTHELIAL WPB EXOCYTOSIS IN AGING BLOOD VESSELS. These experiments will investigate the apparent decreased inhibitory effect of NO signaling in regulating exocytosis in aging endothelium. Experiments will focus on the mechanisms underlying NO regulation of exocytosis. AIM 3: EVALUATE THE PATHOLOGICAL ROLE OF ENDOTHELIAL EXOCYTOSIS IN THE AGING MICROCIRCULATION. These experiments will evaluate the potential pathophysiological role of dysregulated endothelial exocytosis in aging. This will be achieved by investigating the role of exocytosis in the microvascular responses of young and aging animals to ischemia- reperfusion of the mesenteric circulation.
PUBLIC HEALTH RELEVANCE: The Johns Hopkins physician and icon of modern medicine, Sir William Osler (1849-1919) commented that we are only as old as our arteries. We now know that we may only be as old as our endothelium. This project proposes to analyze the influence of aging on a fundamental mechanism of endothelial function (stimulated exocytosis), and to evaluate its role in stress- induced microvascular dysfunction associated with aging organs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impaired Endothelial Maturation and the Developmental Origin of Vascular Disease
-
批准号:9279232
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2014
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Impaired Endothelial Maturation and the Developmental Origin of Vascular Disease
-
批准号:8759467
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2014
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Impaired Endothelial Maturation and the Developmental Origin of Vascular Disease
-
批准号:9085330
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2014
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Endothelial exocytosis and the vascular dysfunction of aging
-
批准号:8059698
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2010
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Mechanisms of Vascular Dysfunction in Vibration Injury
-
批准号:7390919
-
项目类别:
-
资助金额:$25.38万
-
财政年份:2006
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Mechanisms of Vascular Dysfunction in Vibration Injury
-
批准号:7422526
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2006
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Mechanisms of Vascular Dysfunction in Vibration Injury
-
批准号:7491610
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Mechanisms of Vascular Dysfunction in Vibration Injury
-
批准号:7255586
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
alpha2C Adrenergic Receptors & Cutaneous Circulation
-
批准号:6903241
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
alpha2C Adrenergic Receptors & Cutaneous Circulation
-
批准号:7013153
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
alpha2C Adrenergic Receptors & Cutaneous Circulation
-
批准号:7171870
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
alpha2C Adrenergic Receptors & Cutaneous Circulation
-
批准号:7568200
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
alpha2C Adrenergic Receptors & Cutaneous Circulation
-
批准号:7383892
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Mechanisms of Vascular Dysfunction in Vibration Injury
-
批准号:7635844
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Mechanisms of Vascular Dysfunction in Vibration Injury
-
批准号:6959114
-
项目类别:
-
资助金额:$22.94万
-
财政年份:2005
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
ENDOTHELIAL CELL DYSFUNCTION & APOPOTOSIS IN ACCELERATED GRAFT ARTERIOSCLEROSIS
-
批准号:6642364
-
项目类别:
-
资助金额:$49.81万
-
财政年份:2001
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Redox Regulation of Arteriole Function
-
批准号:6499178
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2001
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Redox Regulation of Arteriole Function
-
批准号:6852692
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2001
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Redox Regulation of Arteriole Function
-
批准号:6697310
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2001
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
Redox Regulation of Arteriole Function
-
批准号:6323901
-
项目类别:
-
资助金额:$35.58万
-
财政年份:2001
-
负责人:NICHOLAS A FLAVAHAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: